Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2005 1
2009 1
2010 1
2012 2
2018 1
2019 2
2020 6
2021 7
2022 4
2023 3
2024 4
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Berberine in the Treatment of Diabetes Mellitus: A Review.
Baska A, Leis K, Gałązka P. Baska A, et al. Among authors: leis k. Endocr Metab Immune Disord Drug Targets. 2021;21(8):1379-1386. doi: 10.2174/1568026620666201022144405. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33092516 Review.
Endocrine systems of the skin.
Leis K, Mazur E, Jabłońska MJ, Kolan M, Gałązka P. Leis K, et al. Postepy Dermatol Alergol. 2019 Oct;36(5):519-523. doi: 10.5114/ada.2019.89502. Epub 2019 Nov 12. Postepy Dermatol Alergol. 2019. PMID: 31839767 Free PMC article. Review.
Genistein in the Treatment of Hypertension: A Review.
Sigowska P, Zimoch M, Baska A, Kazik J, Leis K, Grześk G. Sigowska P, et al. Among authors: leis k. Endocr Metab Immune Disord Drug Targets. 2022;22(14):1367-1377. doi: 10.2174/1871530322666220510125115. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35538809 Review.
Pridopidine in the treatment of Huntington's disease.
Jabłońska M, Grzelakowska K, Wiśniewski B, Mazur E, Leis K, Gałązka P. Jabłońska M, et al. Among authors: leis k. Rev Neurosci. 2020 May 26;31(4):441-451. doi: 10.1515/revneuro-2019-0085. Rev Neurosci. 2020. PMID: 32083454 Review.
Resveratrol in the treatment of asthma based on an animal model.
Leis K, Gałązka P, Kazik J, Jamrożek T, Bereźnicka W, Czajkowski R. Leis K, et al. Postepy Dermatol Alergol. 2022 Jun;39(3):433-438. doi: 10.5114/ada.2022.117543. Epub 2022 Jul 15. Postepy Dermatol Alergol. 2022. PMID: 35950118 Free PMC article. Review.
Persistent hyperbilirubinemia in a 1-week-old male.
White S, Tehseen S, Leis KS, Hewitt MJ, Yau D. White S, et al. Among authors: leis ks. Paediatr Child Health. 2024 Nov 15;30(1):1-3. doi: 10.1093/pch/pxae081. eCollection 2025 Feb. Paediatr Child Health. 2024. PMID: 40061251 Free PMC article. No abstract available.
Effect of Mirabegron on the Body's Exercise Capacity: A Review.
Leis K, Mazur E, Racinowski M, Świerczyński W, Baska A, Gałązka P. Leis K, et al. Endocr Metab Immune Disord Drug Targets. 2020;20(9):1448-1455. doi: 10.2174/1871530320666200516164434. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32416711 Review.
Resveratrol in the treatment of neuroblastoma: a review.
Leis K, Baska A, Bereźnicka W, Marjańska A, Mazur E, Lewandowski BT, Kałużny K, Gałązka P. Leis K, et al. Rev Neurosci. 2020 Sep 14:/j/revneuro.ahead-of-print/revneuro-2020-0021/revneuro-2020-0021.xml. doi: 10.1515/revneuro-2020-0021. Online ahead of print. Rev Neurosci. 2020. PMID: 32920543
31 results